Cvs Health Corporation (CVS)

From the record

Cvs Health Corporation's filings since 2017 show 1 warning event: a debt default or acceleration notice (8-K item 2.04, the latest 2023-05-02) (its current reports).

From the record

Cvs Health Corporation's 10 filed years say what it did: revenue went from $178 billion in fiscal 2016 to $402 billion in fiscal 2025, up 9.5% a year; it rose in 9 of 9 years; it never fell from a peak; net income was positive in 9 of 10 of those years (its annual reports).

From the record

Over the 3 fiscal years to 2025-12-31, Cvs Health Corporation's diluted share count shrank about 1.3% a year, and dividends and buybacks returned about 45% of its operating cash flow over 3 years (its filed statements). Its officers and directors filed 8 sales and 1 purchase of their own stock on the open market in the year to 2026-11-06, buying about $2 million (their Form 4 filings).

From the record

Return on equity: in the fiscal year ended 2025-12-31, Cvs Health Corporation earned about 2 cents of profit for every dollar of shareholders' money, and gross profitability: its products earned about 71 cents per dollar of everything the company owns (revenue less the cost of revenue). Leverage: it owed about 70 cents per dollar of assets, and net share issuance: its share count grew 0.7% over the year (the filed statements).

From the record

Cvs Health Corporation's standing among 18 graded names in its industry family: revenue of $402 billion in fiscal 2025 ranks in the top 3% by size; a net margin of 0.4% ranks in the bottom 47%; revenue growth of 7.6% a year over the last 3 filed years ranks in the top 19% (its annual reports).

From the record

Cvs Health Corporation's leadership, from its insiders' filings and its current reports: the chief executive on the record is Joyner, J. David (President, CEO and Chair, as filed), filing under that title since the record of its people begins (2024-11-15), so the years before are not on the record and this part is not read; the 22 officers and directors filing in the last fifteen months have been on the record a median of 3.4 years (bottom 28%); 9 officer or director changes were reported on Form 8-K since 2023-11-13, against the 22 people in charge now (top 32%; fewer changes for each person reads higher) (the Form 4 record, its Form 8-K reports). Years count from a person's first filing in the SEC's data sets, which begin in 2006, so each is a floor.

From the record

Cvs Health Corporation's room to grow, from the newest filed statements (fiscal 2025): cash of $8.5 billion against debt of $61 billion leaves -20.5% of its assets as net cash, bottom 3% of its family; cash from operations less capital spending is 1.9% of revenue (top 42%); a gross margin of 45% (top 15%) (its annual report).

From the record

Cvs Health Corporation's growth drivers, from the filed years to fiscal 2025: revenue grew 7.6% a year over the last three filed years against 9.5% over all 10, slowing (top 41% of its family); the newest year grew 7.9% (top 34%); capital spending grew 1.3% a year (top 47%) (its annual reports). Cvs Health Corporation reported 3 lines of business in fiscal 2025: Health Services at $190 billion, Health Care Benefits at $143 billion, Pharmacy and Consumer Health at $139 billion. 3 of 3 grew in the latest filed year, and the largest line is 40% of revenue (its annual report).

From the record

Cvs Health Corporation's newest year against its own record: revenue of $402 billion in fiscal 2025 came in 0.3% above the $401 billion its prior three years' pace pointed to (bottom 37% of its family); net income of $1.7 billion against a prior three-year average of $5.8 billion (bottom 30%); a net margin of 0.4% against 1.6% before (top 43%) (its annual reports).